D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 125 Citations 61,946 874 World Ranking 1261 National Ranking 41

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Cancer

Stefan Zeuzem mostly deals with Internal medicine, Gastroenterology, Hepatitis C virus, Immunology and Ribavirin. His research is interdisciplinary, bridging the disciplines of Viral load and Internal medicine. His Gastroenterology research integrates issues from Randomized controlled trial, Surgery, Peginterferon alfa-2a, Sofosbuvir and Placebo.

His Hepatitis C virus study integrates concerns from other disciplines, such as Alpha interferon and Genotype. The various areas that he examines in his Ribavirin study include Interferon and Pharmacology. His work in Hepatitis C addresses subjects such as Voxilaprevir, which are connected to disciplines such as Pibrentasvir and Glecaprevir.

His most cited work include:

  • Sorafenib in Advanced Hepatocellular Carcinoma (7596 citations)
  • Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. (2656 citations)
  • Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus (2258 citations)

What are the main themes of his work throughout his whole career to date?

Stefan Zeuzem focuses on Internal medicine, Gastroenterology, Hepatitis C virus, Ribavirin and Immunology. Internal medicine connects with themes related to Pegylated interferon in his study. His Gastroenterology research is multidisciplinary, relying on both Placebo, Chronic hepatitis and Regimen, Surgery.

The study incorporates disciplines such as Interferon, Viral load and Genotype in addition to Hepatitis C virus. His studies deal with areas such as Alpha interferon and Combination therapy, Pharmacology as well as Ribavirin. His Hepatitis C research includes elements of Viral hepatitis, Clinical trial and Hepatitis.

He most often published in these fields:

  • Internal medicine (51.42%)
  • Gastroenterology (33.88%)
  • Hepatitis C virus (27.09%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (51.42%)
  • Gastroenterology (33.88%)
  • Cirrhosis (15.06%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Gastroenterology, Cirrhosis, Hepatitis C and Hepatitis C virus. His research links Chronic hepatitis with Internal medicine. His Gastroenterology research incorporates themes from Hepatitis B, Regimen, Hepatocellular carcinoma, Grazoprevir and Elbasvir.

His Cirrhosis research incorporates elements of Inflammation, Systemic inflammation, Immunology, Liver disease and Innate immune system. He combines subjects such as Elbasvir, Grazoprevir, Ribavirin, Meta-analysis and Hepatitis with his study of Hepatitis C. Stefan Zeuzem usually deals with Hepatitis C virus and limits it to topics linked to Genotype and Virology.

Between 2018 and 2021, his most popular works were:

  • Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial (47 citations)
  • Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis (44 citations)
  • The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. (36 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Cancer

Internal medicine, Gastroenterology, Cirrhosis, Hepatitis C virus and Hepatitis C are his primary areas of study. Stefan Zeuzem incorporates Internal medicine and In patient in his research. His biological study spans a wide range of topics, including Hepatitis B, Chronic hepatitis, Regimen, Adverse effect and Clinical endpoint.

His Cirrhosis research is multidisciplinary, incorporating elements of Bilirubin and Organ dysfunction. His Hepatitis C virus study combines topics from a wide range of disciplines, such as Genotype and Hepatitis. His research in Hepatitis C intersects with topics in Hepatocellular carcinoma, Guideline and Virologic response.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet;Sergio Ricci;Vincenzo Mazzaferro;Philip Hilgard.
The New England Journal of Medicine (2008)

12216 Citations

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Stephanos J. Hadziyannis;Hoel Sette;Timothy R. Morgan;Vijayan Balan.
Annals of Internal Medicine (2004)

3955 Citations

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Thierry Poynard;Patrick Marcellin;Samuel S Lee;Christian Niederau.
The Lancet (1998)

3662 Citations

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

Ira M. Jacobson;John G. McHutchison;Geoffrey Dusheiko;Adrian M. Di Bisceglie.
The New England Journal of Medicine (2011)

3147 Citations

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

Bruce R. Bacon;Stuart C. Gordon;Eric Lawitz;Patrick Marcellin.
The New England Journal of Medicine (2011)

2162 Citations

Telaprevir for retreatment of HCV infection.

Stefan Zeuzem;Pietro Andreone;Stanislas Pol;Eric Lawitz.
The New England Journal of Medicine (2011)

2089 Citations

Treatment of HCV infection by targeting microRNA

Harry L A Janssen;Hendrik W Reesink;Eric J Lawitz;Stefan Zeuzem.
The New England Journal of Medicine (2013)

2066 Citations

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

Nezam Afdhal;Stefan Zeuzem;Paul Kwo;Mario Chojkier.
The New England Journal of Medicine (2014)

1921 Citations

Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis

Mireen Friedrich-Rust;Mei-Fang Ong;Swantje Martens;Christoph Sarrazin.
Gastroenterology (2008)

1875 Citations

Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis

Richard Moreau;Rajiv Jalan;Pere Gines;Marco Pavesi.
Gastroenterology (2013)

1688 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Stefan Zeuzem

Michael P. Manns

Michael P. Manns

Hannover Medical School

Publications: 221

Jean-Michel Pawlotsky

Jean-Michel Pawlotsky

Université Paris Cité

Publications: 219

Zobair M. Younossi

Zobair M. Younossi

Inova Health System

Publications: 204

Heiner Wedemeyer

Heiner Wedemeyer

Hannover Medical School

Publications: 202

Josep M. Llovet

Josep M. Llovet

Icahn School of Medicine at Mount Sinai

Publications: 195

Kazuaki Chayama

Kazuaki Chayama

Hiroshima University

Publications: 190

Masatoshi Kudo

Masatoshi Kudo

Kindai University

Publications: 184

Patrick Marcellin

Patrick Marcellin

Université Paris Cité

Publications: 183

Gregory J. Dore

Gregory J. Dore

University of New South Wales

Publications: 177

Hiromitsu Kumada

Hiromitsu Kumada

Fukuoka University

Publications: 168

Maria Buti

Maria Buti

Instituto de Salud Carlos III

Publications: 162

Fabien Zoulim

Fabien Zoulim

Inserm : Institut national de la santé et de la recherche médicale

Publications: 161

Kwang Hyub Han

Kwang Hyub Han

Yonsei University

Publications: 159

Antonio Craxì

Antonio Craxì

University of Palermo

Publications: 157

Stanislas Pol

Stanislas Pol

Université Paris Cité

Publications: 151

Jia-Horng Kao

Jia-Horng Kao

National Taiwan University

Publications: 149

Trending Scientists

Sennur Ulukus

Sennur Ulukus

University of Maryland, College Park

Zhen-Qing Chen

Zhen-Qing Chen

University of Washington

Isao Mochida

Isao Mochida

Kyushu University

Johji Yamahara

Johji Yamahara

Kyoto Pharmaceutical University

Guy Daculsi

Guy Daculsi

University of Nantes

Jan Jansa

Jan Jansa

Czech Academy of Sciences

Alan H. Fairlamb

Alan H. Fairlamb

University of Dundee

Charles B. Kimmel

Charles B. Kimmel

University of Oregon

Sylvie Robine

Sylvie Robine

Institute Curie

Tomohisa Ogawa

Tomohisa Ogawa

Tohoku University

Sean R. Cutler

Sean R. Cutler

University of California, Riverside

Eric Oswald

Eric Oswald

Federal University of Toulouse Midi-Pyrénées

Chih-An Huh

Chih-An Huh

Academia Sinica

Jeffrey E. Rubnitz

Jeffrey E. Rubnitz

St. Jude Children's Research Hospital

Carolyn S.P. Lam

Carolyn S.P. Lam

National University of Singapore

Something went wrong. Please try again later.